Swissmedic issues updates on reporting quality deficiencies and variations
This article was originally published in SRA
Executive Summary
Swiss drug regulator Swissmedic has revised its procedures for reporting quality deficiencies in order to adopt internationally applied standards to quality risk assessment1,2.
You may also be interested in...
A milestone meeting and the way forward: 10 years of Swissmedic
Alan Chalmers reports from the Swiss agency’s International Regulatory Symposium.
New Swiss requirements on submissions for generics and products with known APIs get industry thumbs up
Recently implemented Swiss rules relating to marketing submissions for generics and products with known active pharmaceutical ingredients make the application process clearer and enable regulatory timeframes to be maintained.
ICH steering committee expands global reach at 20th anniversary meeting
International Conference on Harmonisation technical working groups will now be expanded to allow active participation by experts from qualifying members of the Global Cooperation Group1. This was a key development of the ICH steering committee's meeting in Fukuoka, Japan, which took place from 6-11 November and marked the 20th anniversary of the ICH.